Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
Brief Summary: Objectives

The objective of this study is to help identify the best practice regarding the use of indwelling catheter after minimally invasive urogynecologic surgery. Investigators propose a randomized controlled trial comparing the immediate removal of indwelling urethral catheter, after minimally invasive sacrocolpopexy, to the present standard catheter removal on post operative day one. Evidence based catheter management will be helpful to both providers and patients in post-operative decision making.

Specific Aims

Aim 1: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy results in shorter hospital stay than removal on postoperative day 1.

Aim 2: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy confers no increased risk of re-catheterization.

Aim 3: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy decreases the occurrence of urinary tract infection.

Design

A randomized controlled trial comparing the standard overnight indwelling urethral catheterization with removal of catheter immediately post surgery after minimally invasive sacrocolpopexy, at Oregon Health \& Science University.

Outcome measures

Primary outcome measures are hospital stay in hours after completion of surgery and need for re-catheterization. Hospital stay will be counted from the time the patient leaves the operating room to the time she leaves the hospital. To avoid confounding, investigators are only including the first / morning case of the day. For re-catheterization, investigators will evaluate if patient was able to void after completion of surgery. Investigators will compare the post voiding residuals, the need for re-catheterizations and the numbers of patients going home with an indwelling catheter between the two groups. Investigators will also compare the number of urinary tract infections, as documented by urine culture and subsequent treatment, between the two groups.

Study Subjects

Study subjects will be women undergoing minimally invasive sacrocolpopexy. Women will be invited to participate in the study during their preoperative visit. If they agree to participation, this will be noted in their chart. Randomization to group will occur immediately following surgery.


Options:
A: Arm Label: Immediate catheter removal; Type: EXPERIMENTAL; Interventions: Procedure: Immediate catheter removal | Arm Label: Post op day 1 catheter removal; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Post op day 1 catheter removal | Intervention Type: PROCEDURE; Name: Immediate catheter removal; Assigned to Arm(s): Immediate catheter removal | Intervention Type: PROCEDURE; Name: Post op day 1 catheter removal; Assigned to Arm(s): Post op day 1 catheter removal
B: Arm Label: A B C; Type: EXPERIMENTAL; Interventions: Procedure: on Foley time | Intervention Type: PROCEDURE; Name: on Foley time; Assigned to Arm(s): A B C
C: Arm Label: Autofill Void Trial; Type: ACTIVE_COMPARATOR; Interventions: Device: Void Trial using Foley catheter | Arm Label: Backfill Void Trial; Type: ACTIVE_COMPARATOR; Interventions: Device: Void Trial using Foley catheter | Intervention Type: DEVICE; Name: Void Trial using Foley catheter; Assigned to Arm(s): Autofill Void Trial, Backfill Void Trial
D: Arm Label: Drotaverine; Type: N/A; Interventions: N/A | Arm Label: Control; Type: N/A; Interventions: N/A

Answer: A